Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-03

Clinical Trial Update: Efficacy Study of Ecabet Ophthalmic Solution in Dry Eye Disease [Phase 2]

View source ↗

Summary

Phase 2 efficacy study of ecabet ophthalmic solution in dry eye disease has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ecabet Ophthalmic Solution (ecabet)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Dry Eye Disease | Phase 2 | Status: COMPLETED | Results posted: 2020-09-03